Micro Developing Active

Citi eleva el precio objetivo de MRK

Puntuación
0,4
Velocidad
▲ 0,0
Artículos
9
Fuentes
2

Resumen

Un artículo pertenece a esta narrativa si discute el aumento del precio objetivo de Citi sobre Merck & Co., Inc. (MRK).

Artículos Relacionados

TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61

Yahoo Finance · Abr 04, 2026
Mixed

RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium”

Yahoo Finance · Mar 28, 2026
Mixed

Terns Pharmaceuticals Stock Gains 5% Over Acquisition Deal With Merck

Nasdaq · Mar 25, 2026
Mixed

Citi Raises its Price Target on Merck & Co. (MRK) to $125 from $120

Yahoo Finance · Mar 25, 2026
Mixed

Fuentes

TD Cowen Raises its Price Target on Marex Group plc … Yahoo Finance
Why Marvell Stock Jumped Today Nasdaq
Guggenheim Raises AstraZeneca Price Target Ahead of Q1 Earnings Yahoo Finance
Cantor Fitzgerald Raises United Therapeutics (UTHR) Price Target to $625 Yahoo Finance
Jim Cramer on Merck & Co.: “If We’re Really Going … Yahoo Finance
RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest … Yahoo Finance
Terns Pharmaceuticals Stock Gains 5% Over Acquisition Deal With Merck Nasdaq
Citi Raises its Price Target on Merck & Co. (MRK) … Yahoo Finance

Cronología

Última actualización Mar 25, 2026